RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
ROCKWELL MEDICAL, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$7.49+0.06 (+0.81%)
Close on Oct 19, 2026
- Market cap
- $29.65M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Rockwell Medical has not reported a dividend
No dividend per share appears in Rockwell Medical's annual filings since fiscal 2010.